Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

PREDICTION OF CYP2C9-MEDIATED DRUG-DRUG INTERACTIONS: A COMPARISON USING DATA FROM RECOMBINANT ENZYMES AND HUMAN HEPATOCYTES

Dermot F. McGinnity, James Tucker, Steve Trigg and Robert J. Riley
Drug Metabolism and Disposition November 2005, 33 (11) 1700-1707; DOI: https://doi.org/10.1124/dmd.105.005884
Dermot F. McGinnity
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Tucker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steve Trigg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert J. Riley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 33 no. 11 1700-1707
DOI 
https://doi.org/10.1124/dmd.105.005884
PubMed 
16081671

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received June 1, 2005
  • Accepted August 3, 2005
  • Published online October 26, 2005.

Article Versions

  • Earlier version (August 4, 2005 - 11:14).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Dermot F. McGinnity,
  2. James Tucker,
  3. Steve Trigg and
  4. Robert J. Riley
  1. Department of Physical & Metabolic Science, AstraZeneca R&D Charnwood, Bakewell Rd., Loughborough, Leicestershire, United Kingdom
  1. Address correspondence to:
    Dr. Dermot McGinnity, Department of Physical & Metabolic Science, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, Leicestershire, LE11 5RH, UK. E-mail: dermot.f.mcginnity{at}astrazeneca.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 20170185
Sep 20170166
Oct 20172208
Nov 20171286
Dec 20170103
Jan 20184248
Feb 20180259
Mar 20181137
Apr 201812515
May 20180295
Jun 20184114
Jul 201802711
Aug 20180152
Sep 20180165
Oct 20180132
Nov 20180197
Dec 2018942
Jan 2019730
Feb 2019325
Mar 20191644
Apr 20191432
May 20191233
Jun 2019504
Jul 2019801
Aug 20191102
Oct 20191420
Nov 20191422
Dec 20192674
Jan 20201942
Feb 2020500
Mar 2020743
May 20201163
Jun 2020800
Jul 20201110
Aug 2020401
Sep 2020610
Oct 202015104
Nov 2020522
Dec 20201401
Jan 202118116
Feb 202124114
Mar 20211320
Apr 20214231
May 20213524
Jun 2021982
Jul 2021725
Aug 20211133
Sep 20211133
Oct 202111716
Nov 20211229
Dec 20212333
Jan 2022633
Feb 2022630
Mar 20222547
Apr 20221757
May 2022819
Jun 202222311
Jul 20221949
Aug 20221834
Sep 20221537
Oct 20221666
Nov 20221718
Dec 20222735
Jan 20231742
Feb 20231443
Mar 20233113

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 33 (11)
Drug Metabolism and Disposition
Vol. 33, Issue 11
1 Nov 2005
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
PREDICTION OF CYP2C9-MEDIATED DRUG-DRUG INTERACTIONS: A COMPARISON USING DATA FROM RECOMBINANT ENZYMES AND HUMAN HEPATOCYTES
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

PREDICTION OF CYP2C9-MEDIATED DRUG-DRUG INTERACTIONS: A COMPARISON USING DATA FROM RECOMBINANT ENZYMES AND HUMAN HEPATOCYTES

Dermot F. McGinnity, James Tucker, Steve Trigg and Robert J. Riley
Drug Metabolism and Disposition November 1, 2005, 33 (11) 1700-1707; DOI: https://doi.org/10.1124/dmd.105.005884

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

PREDICTION OF CYP2C9-MEDIATED DRUG-DRUG INTERACTIONS: A COMPARISON USING DATA FROM RECOMBINANT ENZYMES AND HUMAN HEPATOCYTES

Dermot F. McGinnity, James Tucker, Steve Trigg and Robert J. Riley
Drug Metabolism and Disposition November 1, 2005, 33 (11) 1700-1707; DOI: https://doi.org/10.1124/dmd.105.005884
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A PBPK model for CBD in adults and children
  • Antibiotics Induce Changes in the Expression of Rat DPGs
  • Metabolism of Efavirenz by P450s and UGTs in the Brain
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics